Ownership history in BARCLAYS PLC · 30 quarters on record
This page tracks every 13F SEC filing in which BARCLAYS PLC reported a position in ARCTURUS THERAPEUTICS HLDG I (ARCT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 50,589 | -31,363 | -38.3% | 0.00% | $310K | $6.13 |
| 2025 Q3 | ADDED | 81,952 | +13,452 | +19.6% | 0.00% | $1.5M | $18.43 |
| 2025 Q3 | REDUCED | 68,500 | -26,275 | -27.7% | 0.00% | $1.3M | $18.43 |
| 2025 Q2 | ADDED | 94,775 | +47,248 | +99.4% | 0.00% | $1.2M | $13.01 |
| 2025 Q1 | REDUCED | 47,527 | -12,555 | -20.9% | 0.00% | $503K | $10.59 |
| 2024 Q4 | REDUCED | 60,082 | -7,333 | -10.9% | 0.00% | $1.0M | $16.97 |
| 2024 Q3 | ADDED | 67,415 | +22,415 | +49.8% | 0.00% | $1.6M | $23.21 |
| 2024 Q3 | UNCHANGED | 45,000 | — | 0% | 0.00% | $1.0M | $23.21 |
| 2024 Q3 | ADDED | 45,000 | +1,499 | +3.4% | 0.00% | $1.0M | $23.21 |
| 2024 Q2 | REDUCED | 43,501 | -106,499 | -71.0% | 0.00% | $1.1M | $24.35 |
As of 2025 Q4 — sorted by position size